Business Fortune
Six people worldwide sustain needlestick injuries every hour of every day. Three people pass away from those wounds every day. By using ClickZipTM, you can prevent this from happening. Headquarters in Fullarton, South Australia Owner, manufacturer, and distributor of the premium manual retractable needle injectable delivery system with ultra-low dead space, ClickZipTM technology, created in Switzerland, is Numedico. ClickZipTM prevents syringe reuse and needlestick injuries.
Numedico Technologies, a manufacturer and distributor of safety medical equipment with a global emphasis, is the company behind ClickZipTM, having been founded in 2016. Numedico works to question the status quo on a daily basis. Numedico Technologies satisfies this goal by producing home healthcare solutions and medical devices that are safe, dependable, aesthetically pleasing, and functional. Numedico is delivering to major hospitals, health services, government departments, distributors and suppliers, medical practices, veterinary practices, and consumers in need of home healthcare solutions with an expanding range of cutting-edge medical devices and customer solutions.
But Numedico does much more than just innovate and supply trusted medical products to its customers. The company also provides services to pharmaceutical companies and stakeholders in the medical industry. One of its service offerings is its access to life-science research in space. Numedico has partnered with SpaceTech startup ResearchSat to provide life-science research services to pharmaceutical companies. The SpaceTech market is a multi-billion dollar industry that provides a unique environment with extreme environmental variables enabling the acceleration of life-science research.
Innovation Redefined
Since the pandemic began, almost every firm has probably had to rely on innovation. However, it has been essential to succeed in every field. Numedico Technologies has a specialized division for innovation and takes it extremely seriously.
"Innovation is essential to our business and forms its basis. To satisfy the demands of the medical community, we develop continuously. The CEO of Numedico said, "Our Innovation division team manages all elements from product design and engineering to IP acquisition and management and commercialization.
The Innovation branch of Numedico is engaged in projects that address practical issues facing pharmaceutical businesses and healthcare providers. The initiatives have uses in the fields of biotechnology and connectivity.
A new and improved version of ClickZipTM is presently nearing completion as the company completes its design and prototype. The device will be far more efficient than the existing version, even though the changed elements might not be noticeable.
Additionally, Numedico has submitted an Australian provisional patent application under the Project name ZR for a novel syringe. "In due course, we will verify the filing facts. This revolutionary design has the potential to revolutionize the pharmaceutical sector and bring in billions of dollars."
Focus on Safety and Sustainability
The onset of the epidemic has made us all recognize that with hardships comes amazing creativity. By utilizing today's digital channels to expedite the development and delivery of medical equipment and diagnostics while maintaining patient safety, medical technology businesses have significantly transformed their operational processes.
Because of these advancements, MedTech businesses now have the chance to adapt to these developments and move away from manual procedures in favor of advancing digital solutions. This can only speed up the overall product life cycle for them and assist enhance healthcare.
Numedico has eight manufacturing plants in China and India where it makes medical devices. All of its factories hold the necessary certificates, such as TGA authorized, CE marked, US 510k FDA approved, and ISO 13485 certified. At Numedico, sustainability and safety are top priorities. In order to guarantee that sustainable raw materials are used consistently throughout the production process, Numedico collaborates with its manufacturers.
"Despite the fact that COVID posed a significant diversion for the business, there is a bright side: our resources were redirected to expand our sales channels, provide us greater control over the supply chain, and increase the diversity and size of our clientele. It's been a really energizing activity," Mr. Calvert added.
The Quality Assurance department of Numedico monitors production quality by conducting product evaluations in its Australian laboratory. To guarantee quality and consistency, its employees conduct physical inspections on-site. Additionally, Numedico is putting together a feasibility study to construct a syringe and medical device manufacturing plant in North America in order to guard against supply problems in the future. The company is also seeking investors and operators interested in teaming with them to make this vision happen.
"Our logistics group comes up with creative strategies to reduce our carbon impact. The group oversees carbon reduction programs that make our supply chain sustainable," said CEO and founder Neville Calvert. In order to avoid shipping carbon-intensive cargo from Asia, the corporation is also attempting to construct production facilities in regional regions across the globe. Numedico is prepared to stop hundreds of tons of CO2 emissions with this project.
The Future
Numedico recently established Numedico Tech Inc. as a subsidiary in the US. By this calculated move, Numedico will become more visible in the USA and be able to offer its products to American consumers.
"Improving healthcare and identifying the greatest and safest solutions to meet our customers' demands both now and in the future are what motivate us to concentrate on the future. Neville Calvert, the founder and CEO of Numedico Technologies, stated, "We are constantly exploring what's possible, continuously innovating, and seeking new solutions to suit evolving industry and consumer needs."
About the Leader
Neville Calvert, Founder and CEO
Neville is a seasoned strategist and a longtime entrepreneur. Neville held a variety of positions for more than thirty years, including CEO of a private company, partner at the Big Four business consultancy firm KPMG, chairman of the company, and director of a public company. He also has military and international sporting experience.
Neville is in charge of setting the direction, defining the vision, and leading Numedico toward success in his capacity as founder and CEO. He has assembled a superb team around him to assist the company, and he is a superb coach and leader.
"We constantly innovate to meet the needs of the medical community." – Neville Calvert, Founder and CEO
